RTTNews | Dec 11, 2021 12:08PM EST

12:07 Saturday, December 11, 2021 (RTTNews) - Regeneron : REGN5458 Phase 1 Data Show 75% Response Rate At Highest Dose Levels In Heavily Pretreated Multiple Myeloma

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved